Review of oxidative stress in relevance to uremia

US Renal Data System, 2007 Hage, 2009, The scope of coronary heart disease in patients with chronic kidney disease, J Am Coll Cardiol, 53, 2129, 10.1016/j.jacc.2009.02.047 Stenvinkel, 2001, Inflammatory and atherosclerotic interactions in the depleted uremic patient, Blood Purif, 19, 53, 10.1159/000014479 Pecoits-Filho, 2002, The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter, Nephrol Dial Transplant, 17, 28, 10.1093/ndt/17.suppl_11.28 Griendling, 2003, Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS, Circulation, 108, 1912, 10.1161/01.CIR.0000093660.86242.BB Himmelfarb, 2005, Relevance of oxidative pathways in the pathophysiology of chronic kidney disease, Cardiol Clin, 23, 319, 10.1016/j.ccl.2005.03.005 Small, 2012, Oxidative stress, anti-oxidant therapies and chronic kidney disease, Nephrology, 17, 311, 10.1111/j.1440-1797.2012.01572.x Miyata, 2001, Reactive carbonyl compounds related uremic toxicity (‘carbonyl-stress’), Kidney Int Suppl, 78, S25, 10.1046/j.1523-1755.2001.07833.x Galli, 2007, Protein damage and inflammation in uraemia and dialysis patients, Nephrol Dial Transplant, 22, v20, 10.1093/ndt/gfm294 Roche, 2008, The antioxidant properties of serum albumin, FEBS Lett, 582, 1783, 10.1016/j.febslet.2008.04.057 Nguyen-Khoa, 2001, Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment, Nephrol Dial Transplant, 16, 335, 10.1093/ndt/16.2.335 Schindler, 2004, Causes and therapy of microinflammation in renal failure, Nephrol Dial Transplant, 19, v34, 10.1093/ndt/gfh1054 Tomo, 2007, Effect of hemodiafiltration against radical stress in the course of blood purification, Contrib Nephrol, 158, 94 Calo, 2007, Effect of hemodiafiltration with on-line regeneration of ultrafiltrate on oxidative stress in dialysis patients, Nephrol Dial Transplant, 22, 1413, 10.1093/ndt/gfl783 Filiopoulos, 2009, Inflammation and oxidative stress in dialysis patients: the impact of renal replacement treatment, CIN Van Biesen, 2007, Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis, Nephrol Dial Transplant, 22, 53, 10.1093/ndt/gfl601 Vural, 2005, Assessment of oxidative stress in the early post-transplant period: comparison of cyclosporine A and tacrolimus-based regimens, Am J Nephrol, 25, 250, 10.1159/000086079 Perrea, 2006, Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function, Int Urol Nephrol, 38, 343, 10.1007/s11255-006-0054-x Favreau, 2004, Cyclooxygenase 1-dependent production of F2-isoprostane and changes in redox status during warm renal ischemia-reperfusion, Free Radic Biol Med, 36, 1034, 10.1016/j.freeradbiomed.2004.01.010 Himmelfarb, 2002, The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia, Kidney Int, 62, 1524, 10.1046/j.1523-1755.2002.00600.x Kuhlmann, 2008, Potential interplay between nutrition and inflammation in dialysis patients, Contrib Nephrol, 161, 76, 10.1159/000129759 Marques de Mattos, 2012, Protein oxidative stress and dyslipidemia in dialysis patients, Ther Apher Dial, 16, 68, 10.1111/j.1744-9987.2011.01009.x Himmelfarb, 2004, Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?, Semin Dial, 17, 449, 10.1111/j.0894-0959.2004.17605.x Mezzano, 2001, Inflammation, not homocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia, Kidney Int, 60, 1844, 10.1046/j.1523-1755.2001.00998.x Cachofeiro, 2008, Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease, Kidney Int, 74, 54, 10.1038/ki.2008.516 Locatelli1, 2003, Oxidative stress in end-stage renal disease: an emerging threat to patient outcome, Nephrol Dial Transplant, 18, 1272, 10.1093/ndt/gfg074 Aby-Soud, 2001, Peroxidases inhibit nitric oxide (NO)-dependent bronchodilation: development of a model describing NO – peroxidase interactions, Biochemistry, 40, 11866, 10.1021/bi011206v Vecchio, 2011, What we know about oxidative stress in patients with chronic kidney disease on dialysis—clinical effects, potential treatment, and prevention, Semin Dial, 24, 56, 10.1111/j.1525-139X.2010.00819.x Satoh, 2001, Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters, Kidney Int, 59, 1943, 10.1046/j.1523-1755.2001.0590051943.x Izuhara, 2004, Ultrapure dialysate decreases plasma pentosidine, a Marker of “carbonyl Stress”, Am J Kidney Dis, 43, 1024, 10.1053/j.ajkd.2004.02.015 Serbinova, 1991, Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol, Free Radic Biol Med, 10, 263, 10.1016/0891-5849(91)90033-Y Boaz, 2000, Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomised placebo-controlled trial, Lancet, 356, 1213, 10.1016/S0140-6736(00)02783-5 Morimoto, 2005, Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients, Nephrol Dial Transplant, 20, 2775, 10.1093/ndt/gfi121 Prasad, 2003, Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin, J Cardiovasc Pharmacol Ther, 8, 61, 10.1177/107424840300800i109 Stenvinkel, 2002, Inflammation in end-stage renal failure: could it be treated?, Nephrol Dial Transplant, 17, 33, 10.1093/ndt/17.suppl_8.33 Ikonomidis, 1999, Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin, Circulation, 100, 793, 10.1161/01.CIR.100.8.793 Stoll, 2004, Antioxidant effects of statins, Drugs Today (Barc), 40, 975, 10.1358/dot.2004.40.12.872573 Kao, 2011, Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease, J Am Soc Nephrol, 22, 1382, 10.1681/ASN.2010111185 Peres, 2009, Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients, Hemodial Int, 13, 271, 10.1111/j.1542-4758.2009.00369.x Renke, 2008, The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo controlled, randomized, open, cross-over study, Kidney Blood Press Res, 31, 404, 10.1159/000185828 Peake, 2011, The effects of dietary fish oil on inflammation, fibrosis and oxidative stress associated with obstructive renal injury in rats, Mol Nutr Food Res, 55, 400, 10.1002/mnfr.201000195 Thornalley, 2003, Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation end-products, Arch Biochem Biophys, 419, 31, 10.1016/j.abb.2003.08.013 Macdougall, 2004, Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?, Nephrol Dial Transplant, 19, v73, 10.1093/ndt/gfh1060 Oberg, 2004, Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease, Kidney Int, 65, 1009, 10.1111/j.1523-1755.2004.00465.x Fassett, 2011, Biomarkers in chronic kidney disease: a review, Kidney Int, 80, 806, 10.1038/ki.2011.198 Simmons, 2005, Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients, Transplantation, 79, 914, 10.1097/01.TP.0000157773.96534.29 Haubitz, 2001, C-reactive protein and chronic Chlamydia pneumonia infection—long term predictors of cardiovascular disease survival in patients on peritoneal dialysis, Nephrol Dial Transplant, 16, 809, 10.1093/ndt/16.4.809 Spittle, 2000, Relationship between antibodies to peridontal pathogens and C-reactive protein (CRP) levels in haemodialysis patients [abstract], J Am Soc Nephrol, 11, 299A Vanholder, 1996, 1 Sommerburg, 1998, Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?, Nephrol Dial Transplant, 13, 2583, 10.1093/ndt/13.10.2583 Niebauer, 1999, Endotoxin and immune activation in chronic heart failure: a prospective cohort study, Lancet, 353, 1838, 10.1016/S0140-6736(98)09286-1 Calabrese, 2007, Oxidative stress and cellular stress response in diabetic nephropathy, Cell Stress Chaperones, 12, 299, 10.1379/CSC-270.1 Fassett, 2011, Biomarkers in chronic kidney disease: a review, Kidney Int, 80, 806, 10.1038/ki.2011.198 Jofre, 2006, Inflammatory syndrome in patients on hemodialysis, J Am Soc Nephrol, 17, 274, 10.1681/ASN.2006080926 Walker, 2004, Effect of changing from a cellulose acetate to a polysulfone dialysis membrane on protein oxidation and inflammation markers, Clin Nephrol, 61, 198, 10.5414/CNP61198 Ouseph, 2003, Use of ultrafiltered dialysate reduces inflammation in hemodialysis patients, J Am Soc Nephrol, 14, 30A Cappelli, 2005, Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis, Nephrol Dial Transplant, 20, 266, 10.1093/ndt/gfh571 Pecoits-Filho, 2004, Chronic inflammation in peritoneal dialysis: the search for the holy grail?, Perit Dial Int, 24, 327, 10.1177/089686080402400407 Lai, 2010, Inflammation in peritoneal dialysis, Nephron Clin Pract, 116, 11, 10.1159/000314544 López-Gómez, 2004, Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance, J Am Soc Nephrol, 15, 2494, 10.1097/01.ASN.0000137879.97445.6E